Annapolis Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1
Closed -$78 – 465
2022
Q4
$78 Sell
1
-481
-100% -$39K ﹤0.01% 430
2022
Q3
$39K Buy
482
+379
+368% +$34.1K 0.01% 192
2022
Q2
$9K Buy
103
+1
+1% +$101 ﹤0.01% 298
2022
Q1
$11K Sell
102
-23
-18% -$2.43K ﹤0.01% 294
2021
Q4
$13K Buy
125
+23
+23% +$2.66K ﹤0.01% 293
2021
Q3
$13K Sell
102
-29
-22% -$3.75K ﹤0.01% 272
2021
Q2
$16K Buy
131
+22
+20% +$2.76K 0.01% 238
2021
Q1
$13K Buy
109
+7
+7% +$820 ﹤0.01% 239
2020
Q4
$12K Buy
+102
New +$11.2K ﹤0.01% 236

Other funds holding MDT

Annapolis Financial Services's MDT Position: Q1 2023 in Review

Annapolis Financial Services sold out of Medtronic (MDT) in Q1 2023, closing a stake of 1 share — an estimated $78 sold.

Annapolis Financial Services first reported a position in MDT in Q4 2020 and held it in 9 quarters. The position peaked at $39K in Q3 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Annapolis Financial Services reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Annapolis Financial Services sold 1 Medtronic share in Q1 2023, an estimated $78.
  • Annapolis Financial Services first reported a position in Medtronic in Q4 2020 and held it in 9 quarters.
  • Annapolis Financial Services's Medtronic position peaked at $39K in Q3 2022.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Annapolis Financial Services's 13F filing for Q1 2023, filed 17 Apr 2023.